Jayathilaka, N.; Pathirana, T.; Kumari, C.; Navaratne, V.; Gunasekara, S.; Nakkawita, D.; Senaratne, T. Fosfomycin: A Potential Oral Option for Treatment of Urinary Tract Infections in Sri Lanka in the Context of High Antibiotic Resistance. GERMS 2023, 13, 314-320. https://doi.org/10.18683/germs.2023.1400

AMA Style

Jayathilaka N, Pathirana T, Kumari C, Navaratne V, Gunasekara S, Nakkawita D, Senaratne T. Fosfomycin: A Potential Oral Option for Treatment of Urinary Tract Infections in Sri Lanka in the Context of High Antibiotic Resistance. GERMS. 2023; 13(4):314-320. https://doi.org/10.18683/germs.2023.1400

Chicago/Turabian Style

Jayathilaka, Nishadi, Tharushi Pathirana, Chathurika Kumari, Varuna Navaratne, Samanmalee Gunasekara, Dilini Nakkawita, and Thamarasi Senaratne. 2023. "Fosfomycin: A Potential Oral Option for Treatment of Urinary Tract Infections in Sri Lanka in the Context of High Antibiotic Resistance" GERMS 13, no. 4: 314-320. https://doi.org/10.18683/germs.2023.1400

APA Style

Jayathilaka, N., Pathirana, T., Kumari, C., Navaratne, V., Gunasekara, S., Nakkawita, D., & Senaratne, T. (2023). Fosfomycin: A Potential Oral Option for Treatment of Urinary Tract Infections in Sri Lanka in the Context of High Antibiotic Resistance. GERMS, 13(4), 314-320. https://doi.org/10.18683/germs.2023.1400

Article Metrics

Article Access Statistics

For more information on the journal statistics, click here.

Multiple requests from the same IP address are counted as one view.

Article Menu

Article Versions Notes

Further Information

Guidelines

MDPI Initiatives

Follow MDPI